 | • レポートコード：MMG23DC14321 • 出版社/出版日：Market Monitor Global / 2023年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、79ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品 |
| Single User（1名様閲覧用） | ￥471,250 (USD3,250) | ▷ お問い合わせ |
| Multi User（20名様閲覧用） | ￥612,625 (USD4,225) | ▷ お問い合わせ |
| Enterprise User（閲覧人数制限なし） | ￥706,875 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の人間用フィブリンシーラント市場規模と予測を収録しています。・世界の人間用フィブリンシーラント市場：売上、2018年-2023年、2024年-2029年 ・世界の人間用フィブリンシーラント市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の人間用フィブリンシーラント市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「2mL/セット」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 人間用フィブリンシーラントのグローバル主要企業は、Baxter、 CSL、 Bayer、 Grifols、 Octapharma、 Shanghai RAAS、 Hualan Biological、 Immuno、 Behringwerke、 ETHICON( Johnson & Johnson)、 Baxter International、 B. Braun Melsunge、 Takeda Pharmaceutical Company、 Omrix Biopharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、人間用フィブリンシーラントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の人間用フィブリンシーラント市場：タイプ別、2018年-2023年、2024年-2029年 世界の人間用フィブリンシーラント市場：タイプ別市場シェア、2022年 ・2mL/セット、4mL/セット、10mL/セット 世界の人間用フィブリンシーラント市場：用途別、2018年-2023年、2024年-2029年 世界の人間用フィブリンシーラント市場：用途別市場シェア、2022年 ・病院、クリニック、その他 世界の人間用フィブリンシーラント市場：地域・国別、2018年-2023年、2024年-2029年 世界の人間用フィブリンシーラント市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における人間用フィブリンシーラントのグローバル売上、2018年-2023年 ・主要企業における人間用フィブリンシーラントのグローバル売上シェア、2022年 ・主要企業における人間用フィブリンシーラントのグローバル販売量、2018年-2023年 ・主要企業における人間用フィブリンシーラントのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Baxter、 CSL、 Bayer、 Grifols、 Octapharma、 Shanghai RAAS、 Hualan Biological、 Immuno、 Behringwerke、 ETHICON( Johnson & Johnson)、 Baxter International、 B. Braun Melsunge、 Takeda Pharmaceutical Company、 Omrix Biopharmaceuticals ************************************************************* ・調査・分析レポートの概要 人間用フィブリンシーラント市場の定義 市場セグメント 世界の人間用フィブリンシーラント市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の人間用フィブリンシーラント市場規模 世界の人間用フィブリンシーラント市場規模：2022年 VS 2029年 世界の人間用フィブリンシーラント市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの人間用フィブリンシーラントの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の人間用フィブリンシーラント製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：2mL/セット、4mL/セット、10mL/セット 人間用フィブリンシーラントのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック、その他 人間用フィブリンシーラントの用途別グローバル売上・予測 ・地域別市場分析 地域別人間用フィブリンシーラント市場規模 2022年と2029年 地域別人間用フィブリンシーラント売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Baxter、 CSL、 Bayer、 Grifols、 Octapharma、 Shanghai RAAS、 Hualan Biological、 Immuno、 Behringwerke、 ETHICON( Johnson & Johnson)、 Baxter International、 B. Braun Melsunge、 Takeda Pharmaceutical Company、 Omrix Biopharmaceuticals ... |
This research report provides a comprehensive analysis of the Fibrin Sealants for Humans market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Fibrin Sealants for Humans market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Fibrin Sealants for Humans, challenges faced by the industry, and potential opportunities for market players.
The global Fibrin Sealants for Humans market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Fibrin Sealants for Humans market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Fibrin Sealants for Humans market. Additionally, the growing consumer demand present avenues for market expansion.
The global Fibrin Sealants for Humans market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Fibrin Sealants for Humans market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Fibrin Sealants for Humans market.
Market Overview: The report provides a comprehensive overview of the Fibrin Sealants for Humans market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 2mL/Set, 4mL/Set), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Fibrin Sealants for Humans market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Fibrin Sealants for Humans market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Fibrin Sealants for Humans market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Fibrin Sealants for Humans market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Fibrin Sealants for Humans market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Fibrin Sealants for Humans market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Fibrin Sealants for Humans, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Fibrin Sealants for Humans market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Fibrin Sealants for Humans market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
2mL/Set
4mL/Set
10mL/Set
Market segment by Application
Hospital
Clinic
Others
Global Fibrin Sealants for Humans Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
Immuno
Behringwerke
ETHICON( Johnson & Johnson)
Baxter International
B. Braun Melsunge
Takeda Pharmaceutical Company
Omrix Biopharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fibrin Sealants for Humans, market overview.
Chapter 2: Global Fibrin Sealants for Humans market size in revenue and volume.
Chapter 3: Detailed analysis of Fibrin Sealants for Humans manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fibrin Sealants for Humans in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fibrin Sealants for Humans capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Fibrin Sealants for Humans Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fibrin Sealants for Humans Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fibrin Sealants for Humans Overall Market Size
2.1 Global Fibrin Sealants for Humans Market Size: 2022 VS 2029
2.2 Global Fibrin Sealants for Humans Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fibrin Sealants for Humans Sales: 2018-2029
3 Company Landscape
3.1 Top Fibrin Sealants for Humans Players in Global Market
3.2 Top Global Fibrin Sealants for Humans Companies Ranked by Revenue
3.3 Global Fibrin Sealants for Humans Revenue by Companies
3.4 Global Fibrin Sealants for Humans Sales by Companies
3.5 Global Fibrin Sealants for Humans Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fibrin Sealants for Humans Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fibrin Sealants for Humans Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fibrin Sealants for Humans Players in Global Market
3.8.1 List of Global Tier 1 Fibrin Sealants for Humans Companies
3.8.2 List of Global Tier 2 and Tier 3 Fibrin Sealants for Humans Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fibrin Sealants for Humans Market Size Markets, 2022 & 2029
4.1.2 2mL/Set
4.1.3 4mL/Set
4.1.4 10mL/Set
4.2 By Type – Global Fibrin Sealants for Humans Revenue & Forecasts
4.2.1 By Type – Global Fibrin Sealants for Humans Revenue, 2018-2023
4.2.2 By Type – Global Fibrin Sealants for Humans Revenue, 2024-2029
4.2.3 By Type – Global Fibrin Sealants for Humans Revenue Market Share, 2018-2029
4.3 By Type – Global Fibrin Sealants for Humans Sales & Forecasts
4.3.1 By Type – Global Fibrin Sealants for Humans Sales, 2018-2023
4.3.2 By Type – Global Fibrin Sealants for Humans Sales, 2024-2029
4.3.3 By Type – Global Fibrin Sealants for Humans Sales Market Share, 2018-2029
4.4 By Type – Global Fibrin Sealants for Humans Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fibrin Sealants for Humans Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Fibrin Sealants for Humans Revenue & Forecasts
5.2.1 By Application – Global Fibrin Sealants for Humans Revenue, 2018-2023
5.2.2 By Application – Global Fibrin Sealants for Humans Revenue, 2024-2029
5.2.3 By Application – Global Fibrin Sealants for Humans Revenue Market Share, 2018-2029
5.3 By Application – Global Fibrin Sealants for Humans Sales & Forecasts
5.3.1 By Application – Global Fibrin Sealants for Humans Sales, 2018-2023
5.3.2 By Application – Global Fibrin Sealants for Humans Sales, 2024-2029
5.3.3 By Application – Global Fibrin Sealants for Humans Sales Market Share, 2018-2029
5.4 By Application – Global Fibrin Sealants for Humans Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fibrin Sealants for Humans Market Size, 2022 & 2029
6.2 By Region – Global Fibrin Sealants for Humans Revenue & Forecasts
6.2.1 By Region – Global Fibrin Sealants for Humans Revenue, 2018-2023
6.2.2 By Region – Global Fibrin Sealants for Humans Revenue, 2024-2029
6.2.3 By Region – Global Fibrin Sealants for Humans Revenue Market Share, 2018-2029
6.3 By Region – Global Fibrin Sealants for Humans Sales & Forecasts
6.3.1 By Region – Global Fibrin Sealants for Humans Sales, 2018-2023
6.3.2 By Region – Global Fibrin Sealants for Humans Sales, 2024-2029
6.3.3 By Region – Global Fibrin Sealants for Humans Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fibrin Sealants for Humans Revenue, 2018-2029
6.4.2 By Country – North America Fibrin Sealants for Humans Sales, 2018-2029
6.4.3 US Fibrin Sealants for Humans Market Size, 2018-2029
6.4.4 Canada Fibrin Sealants for Humans Market Size, 2018-2029
6.4.5 Mexico Fibrin Sealants for Humans Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fibrin Sealants for Humans Revenue, 2018-2029
6.5.2 By Country – Europe Fibrin Sealants for Humans Sales, 2018-2029
6.5.3 Germany Fibrin Sealants for Humans Market Size, 2018-2029
6.5.4 France Fibrin Sealants for Humans Market Size, 2018-2029
6.5.5 U.K. Fibrin Sealants for Humans Market Size, 2018-2029
6.5.6 Italy Fibrin Sealants for Humans Market Size, 2018-2029
6.5.7 Russia Fibrin Sealants for Humans Market Size, 2018-2029
6.5.8 Nordic Countries Fibrin Sealants for Humans Market Size, 2018-2029
6.5.9 Benelux Fibrin Sealants for Humans Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fibrin Sealants for Humans Revenue, 2018-2029
6.6.2 By Region – Asia Fibrin Sealants for Humans Sales, 2018-2029
6.6.3 China Fibrin Sealants for Humans Market Size, 2018-2029
6.6.4 Japan Fibrin Sealants for Humans Market Size, 2018-2029
6.6.5 South Korea Fibrin Sealants for Humans Market Size, 2018-2029
6.6.6 Southeast Asia Fibrin Sealants for Humans Market Size, 2018-2029
6.6.7 India Fibrin Sealants for Humans Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fibrin Sealants for Humans Revenue, 2018-2029
6.7.2 By Country – South America Fibrin Sealants for Humans Sales, 2018-2029
6.7.3 Brazil Fibrin Sealants for Humans Market Size, 2018-2029
6.7.4 Argentina Fibrin Sealants for Humans Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fibrin Sealants for Humans Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fibrin Sealants for Humans Sales, 2018-2029
6.8.3 Turkey Fibrin Sealants for Humans Market Size, 2018-2029
6.8.4 Israel Fibrin Sealants for Humans Market Size, 2018-2029
6.8.5 Saudi Arabia Fibrin Sealants for Humans Market Size, 2018-2029
6.8.6 UAE Fibrin Sealants for Humans Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Baxter
7.1.1 Baxter Company Summary
7.1.2 Baxter Business Overview
7.1.3 Baxter Fibrin Sealants for Humans Major Product Offerings
7.1.4 Baxter Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.1.5 Baxter Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Fibrin Sealants for Humans Major Product Offerings
7.2.4 CSL Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Fibrin Sealants for Humans Major Product Offerings
7.3.4 Bayer Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Grifols
7.4.1 Grifols Company Summary
7.4.2 Grifols Business Overview
7.4.3 Grifols Fibrin Sealants for Humans Major Product Offerings
7.4.4 Grifols Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.4.5 Grifols Key News & Latest Developments
7.5 Octapharma
7.5.1 Octapharma Company Summary
7.5.2 Octapharma Business Overview
7.5.3 Octapharma Fibrin Sealants for Humans Major Product Offerings
7.5.4 Octapharma Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.5.5 Octapharma Key News & Latest Developments
7.6 Shanghai RAAS
7.6.1 Shanghai RAAS Company Summary
7.6.2 Shanghai RAAS Business Overview
7.6.3 Shanghai RAAS Fibrin Sealants for Humans Major Product Offerings
7.6.4 Shanghai RAAS Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.6.5 Shanghai RAAS Key News & Latest Developments
7.7 Hualan Biological
7.7.1 Hualan Biological Company Summary
7.7.2 Hualan Biological Business Overview
7.7.3 Hualan Biological Fibrin Sealants for Humans Major Product Offerings
7.7.4 Hualan Biological Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.7.5 Hualan Biological Key News & Latest Developments
7.8 Immuno
7.8.1 Immuno Company Summary
7.8.2 Immuno Business Overview
7.8.3 Immuno Fibrin Sealants for Humans Major Product Offerings
7.8.4 Immuno Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.8.5 Immuno Key News & Latest Developments
7.9 Behringwerke
7.9.1 Behringwerke Company Summary
7.9.2 Behringwerke Business Overview
7.9.3 Behringwerke Fibrin Sealants for Humans Major Product Offerings
7.9.4 Behringwerke Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.9.5 Behringwerke Key News & Latest Developments
7.10 ETHICON( Johnson & Johnson)
7.10.1 ETHICON( Johnson & Johnson) Company Summary
7.10.2 ETHICON( Johnson & Johnson) Business Overview
7.10.3 ETHICON( Johnson & Johnson) Fibrin Sealants for Humans Major Product Offerings
7.10.4 ETHICON( Johnson & Johnson) Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.10.5 ETHICON( Johnson & Johnson) Key News & Latest Developments
7.11 Baxter International
7.11.1 Baxter International Company Summary
7.11.2 Baxter International Business Overview
7.11.3 Baxter International Fibrin Sealants for Humans Major Product Offerings
7.11.4 Baxter International Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.11.5 Baxter International Key News & Latest Developments
7.12 B. Braun Melsunge
7.12.1 B. Braun Melsunge Company Summary
7.12.2 B. Braun Melsunge Business Overview
7.12.3 B. Braun Melsunge Fibrin Sealants for Humans Major Product Offerings
7.12.4 B. Braun Melsunge Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.12.5 B. Braun Melsunge Key News & Latest Developments
7.13 Takeda Pharmaceutical Company
7.13.1 Takeda Pharmaceutical Company Company Summary
7.13.2 Takeda Pharmaceutical Company Business Overview
7.13.3 Takeda Pharmaceutical Company Fibrin Sealants for Humans Major Product Offerings
7.13.4 Takeda Pharmaceutical Company Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.13.5 Takeda Pharmaceutical Company Key News & Latest Developments
7.14 Omrix Biopharmaceuticals
7.14.1 Omrix Biopharmaceuticals Company Summary
7.14.2 Omrix Biopharmaceuticals Business Overview
7.14.3 Omrix Biopharmaceuticals Fibrin Sealants for Humans Major Product Offerings
7.14.4 Omrix Biopharmaceuticals Fibrin Sealants for Humans Sales and Revenue in Global (2018-2023)
7.14.5 Omrix Biopharmaceuticals Key News & Latest Developments
8 Global Fibrin Sealants for Humans Production Capacity, Analysis
8.1 Global Fibrin Sealants for Humans Production Capacity, 2018-2029
8.2 Fibrin Sealants for Humans Production Capacity of Key Manufacturers in Global Market
8.3 Global Fibrin Sealants for Humans Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fibrin Sealants for Humans Supply Chain Analysis
10.1 Fibrin Sealants for Humans Industry Value Chain
10.2 Fibrin Sealants for Humans Upstream Market
10.3 Fibrin Sealants for Humans Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fibrin Sealants for Humans Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Fibrin Sealants for Humans in Global Market
Table 2. Top Fibrin Sealants for Humans Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Fibrin Sealants for Humans Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Fibrin Sealants for Humans Revenue Share by Companies, 2018-2023
Table 5. Global Fibrin Sealants for Humans Sales by Companies, (K Units), 2018-2023
Table 6. Global Fibrin Sealants for Humans Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Fibrin Sealants for Humans Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Fibrin Sealants for Humans Product Type
Table 9. List of Global Tier 1 Fibrin Sealants for Humans Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibrin Sealants for Humans Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Fibrin Sealants for Humans Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Fibrin Sealants for Humans Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Fibrin Sealants for Humans Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Fibrin Sealants for Humans Sales (K Units), 2018-2023
Table 15. By Type - Global Fibrin Sealants for Humans Sales (K Units), 2024-2029
Table 16. By Application – Global Fibrin Sealants for Humans Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Fibrin Sealants for Humans Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Fibrin Sealants for Humans Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Fibrin Sealants for Humans Sales (K Units), 2018-2023
Table 20. By Application - Global Fibrin Sealants for Humans Sales (K Units), 2024-2029
Table 21. By Region – Global Fibrin Sealants for Humans Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Fibrin Sealants for Humans Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Fibrin Sealants for Humans Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Fibrin Sealants for Humans Sales (K Units), 2018-2023
Table 25. By Region - Global Fibrin Sealants for Humans Sales (K Units), 2024-2029
Table 26. By Country - North America Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Fibrin Sealants for Humans Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Fibrin Sealants for Humans Sales, (K Units), 2018-2023
Table 29. By Country - North America Fibrin Sealants for Humans Sales, (K Units), 2024-2029
Table 30. By Country - Europe Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Fibrin Sealants for Humans Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Fibrin Sealants for Humans Sales, (K Units), 2018-2023
Table 33. By Country - Europe Fibrin Sealants for Humans Sales, (K Units), 2024-2029
Table 34. By Region - Asia Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Fibrin Sealants for Humans Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Fibrin Sealants for Humans Sales, (K Units), 2018-2023
Table 37. By Region - Asia Fibrin Sealants for Humans Sales, (K Units), 2024-2029
Table 38. By Country - South America Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Fibrin Sealants for Humans Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Fibrin Sealants for Humans Sales, (K Units), 2018-2023
Table 41. By Country - South America Fibrin Sealants for Humans Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Fibrin Sealants for Humans Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Fibrin Sealants for Humans Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Fibrin Sealants for Humans Sales, (K Units), 2024-2029
Table 46. Baxter Company Summary
Table 47. Baxter Fibrin Sealants for Humans Product Offerings
Table 48. Baxter Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Baxter Key News & Latest Developments
Table 50. CSL Company Summary
Table 51. CSL Fibrin Sealants for Humans Product Offerings
Table 52. CSL Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. CSL Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Fibrin Sealants for Humans Product Offerings
Table 56. Bayer Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Grifols Company Summary
Table 59. Grifols Fibrin Sealants for Humans Product Offerings
Table 60. Grifols Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Grifols Key News & Latest Developments
Table 62. Octapharma Company Summary
Table 63. Octapharma Fibrin Sealants for Humans Product Offerings
Table 64. Octapharma Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Octapharma Key News & Latest Developments
Table 66. Shanghai RAAS Company Summary
Table 67. Shanghai RAAS Fibrin Sealants for Humans Product Offerings
Table 68. Shanghai RAAS Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Shanghai RAAS Key News & Latest Developments
Table 70. Hualan Biological Company Summary
Table 71. Hualan Biological Fibrin Sealants for Humans Product Offerings
Table 72. Hualan Biological Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Hualan Biological Key News & Latest Developments
Table 74. Immuno Company Summary
Table 75. Immuno Fibrin Sealants for Humans Product Offerings
Table 76. Immuno Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Immuno Key News & Latest Developments
Table 78. Behringwerke Company Summary
Table 79. Behringwerke Fibrin Sealants for Humans Product Offerings
Table 80. Behringwerke Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Behringwerke Key News & Latest Developments
Table 82. ETHICON( Johnson & Johnson) Company Summary
Table 83. ETHICON( Johnson & Johnson) Fibrin Sealants for Humans Product Offerings
Table 84. ETHICON( Johnson & Johnson) Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. ETHICON( Johnson & Johnson) Key News & Latest Developments
Table 86. Baxter International Company Summary
Table 87. Baxter International Fibrin Sealants for Humans Product Offerings
Table 88. Baxter International Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Baxter International Key News & Latest Developments
Table 90. B. Braun Melsunge Company Summary
Table 91. B. Braun Melsunge Fibrin Sealants for Humans Product Offerings
Table 92. B. Braun Melsunge Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. B. Braun Melsunge Key News & Latest Developments
Table 94. Takeda Pharmaceutical Company Company Summary
Table 95. Takeda Pharmaceutical Company Fibrin Sealants for Humans Product Offerings
Table 96. Takeda Pharmaceutical Company Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Takeda Pharmaceutical Company Key News & Latest Developments
Table 98. Omrix Biopharmaceuticals Company Summary
Table 99. Omrix Biopharmaceuticals Fibrin Sealants for Humans Product Offerings
Table 100. Omrix Biopharmaceuticals Fibrin Sealants for Humans Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Omrix Biopharmaceuticals Key News & Latest Developments
Table 102. Fibrin Sealants for Humans Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Fibrin Sealants for Humans Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Fibrin Sealants for Humans Production by Region, 2018-2023 (K Units)
Table 105. Global Fibrin Sealants for Humans Production by Region, 2024-2029 (K Units)
Table 106. Fibrin Sealants for Humans Market Opportunities & Trends in Global Market
Table 107. Fibrin Sealants for Humans Market Drivers in Global Market
Table 108. Fibrin Sealants for Humans Market Restraints in Global Market
Table 109. Fibrin Sealants for Humans Raw Materials
Table 110. Fibrin Sealants for Humans Raw Materials Suppliers in Global Market
Table 111. Typical Fibrin Sealants for Humans Downstream
Table 112. Fibrin Sealants for Humans Downstream Clients in Global Market
Table 113. Fibrin Sealants for Humans Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fibrin Sealants for Humans Segment by Type in 2022
Figure 2. Fibrin Sealants for Humans Segment by Application in 2022
Figure 3. Global Fibrin Sealants for Humans Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fibrin Sealants for Humans Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fibrin Sealants for Humans Revenue, 2018-2029 (US$, Mn)
Figure 7. Fibrin Sealants for Humans Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Fibrin Sealants for Humans Revenue in 2022
Figure 9. By Type - Global Fibrin Sealants for Humans Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Fibrin Sealants for Humans Revenue Market Share, 2018-2029
Figure 11. By Type - Global Fibrin Sealants for Humans Sales Market Share, 2018-2029
Figure 12. By Type - Global Fibrin Sealants for Humans Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Fibrin Sealants for Humans Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Fibrin Sealants for Humans Revenue Market Share, 2018-2029
Figure 15. By Application - Global Fibrin Sealants for Humans Sales Market Share, 2018-2029
Figure 16. By Application - Global Fibrin Sealants for Humans Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Fibrin Sealants for Humans Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Fibrin Sealants for Humans Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Fibrin Sealants for Humans Revenue Market Share, 2018-2029
Figure 20. By Region - Global Fibrin Sealants for Humans Sales Market Share, 2018-2029
Figure 21. By Country - North America Fibrin Sealants for Humans Revenue Market Share, 2018-2029
Figure 22. By Country - North America Fibrin Sealants for Humans Sales Market Share, 2018-2029
Figure 23. US Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Fibrin Sealants for Humans Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Fibrin Sealants for Humans Sales Market Share, 2018-2029
Figure 28. Germany Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 29. France Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Fibrin Sealants for Humans Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Fibrin Sealants for Humans Sales Market Share, 2018-2029
Figure 37. China Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 41. India Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Fibrin Sealants for Humans Revenue Market Share, 2018-2029
Figure 43. By Country - South America Fibrin Sealants for Humans Sales Market Share, 2018-2029
Figure 44. Brazil Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Fibrin Sealants for Humans Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Fibrin Sealants for Humans Sales Market Share, 2018-2029
Figure 48. Turkey Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Fibrin Sealants for Humans Revenue, (US$, Mn), 2018-2029
Figure 52. Global Fibrin Sealants for Humans Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Fibrin Sealants for Humans by Region, 2022 VS 2029
Figure 54. Fibrin Sealants for Humans Industry Value Chain
Figure 55. Marketing Channels
| 【人間用フィブリンシーラントについて】 フィブリンシーラントは、手術や外傷の治療に広く使用される医療用接着剤であり、特に止血や組織の接合を目的としています。フィブリンは、血液凝固の過程で生成されるタンパク質で、通常は体内で自然に形成されるものですが、フィブリンシーラントでは人工的に作り出されたフィブリンを用います。この接着剤は、外科手術や外傷処置において効果的に出血を防ぎ、組織の修復を促進する役割を果たします。 フィブリンシーラントの特徴の一つは、その生体適合性です。ヒトの体内で自然に生成される成分を使用するため、アレルギー反応や拒絶反応のリスクが低く、患者の安全性が確保されています。また、フィブリンシーラントは通常、血液または血漿から抽出された成分を利用して作られ、その過程で高度な精製が行われます。これにより、感染症のリスクも最小限に抑えられています。 種類に関しては、フィブリンシーラントは主に二つのタイプに分けられます。第一に、医療用フィブリンシーラントは、成分の供給源によって異なります。例えば、自己血液を使用した自家製フィブリンシーラントや、ドナーからの血液成分を使用した同種フィブリンシーラントがあります。第二に、製剤の形状や使い方に応じた分類があります。例えば、スプレー式やゲル状、シート状のものがあり、それぞれ特定の用途や手技に対して最適化されています。 フィブリンシーラントの用途は非常に幅広く、多くの医療分野で応用されています。外科手術においては、出血を迅速に止めるために利用されることが一般的です。特に心臓手術や脳神経手術では、微細な血管の出血を制御するために不可欠なアイテムとなります。また、整形外科や皮膚科、および歯科においても、組織の再生や創傷の治癒を促進するために用いられています。 さらに、フィブリンシーラントは、外傷や褥瘡（じょくそう）などの慢性創傷の治療にも使用されます。これにより、創傷が適切に閉じられ、感染のリスクが低減されることが期待されます。また、スポーツ医学の分野でも、靭帯や腱の損傷に対してフィブリンシーラントが使用されており、回復速度を向上させる可能性が示唆されています。 フィブリンシーラントに関連する技術の進展も注目されています。最近の研究では、フィブリンシーラントに薬剤を加え、抗菌作用や抗炎症作用を持たせる試みが行われています。こうした新たな技術により、フィブリンシーラントの機能が一層強化され、より高い治療効果が期待できるようになります。加えて、ナノテクノロジーやバイオマテリアルの進歩も、フィブリンシーラントの改良に寄与しています。具体的には、生分解性ポリマーとの組み合わせや、成長因子を放出するフィブリンシーラントの研究が進められており、組織再生を促進する効果が期待されています。 フィブリンシーラントの使用に際しては、いくつかの注意点も存在します。例えば、血液凝固異常を持つ患者や、重度のアレルギー歴のある患者には使用を避けるべきです。また、適切な使用方法を守らない場合、効果が低下したり、逆に組織損傷を引き起こす可能性もあるため、専門的な知識を持った医療従事者による取り扱いが求められます。さらに、使用後の経過観察も重要で、特に出血や感染の兆候に注意を払う必要があります。 総じて、フィブリンシーラントは現代医療の中で重要な役割を果たしており、今後もさまざまな研究と技術の進展によってその応用範囲が広がることが期待されます。新たな治療法や製品が開発されることで、患者の治癒過程がさらに向上し、より効果的な医療が提供されるようになっていくでしょう。フィブリンシーラントの進化は、医療現場における新たな可能性を提示するものであり、今後の展望にも大いに期待が寄せられています。 |
